☰

Matthew K. Brittain, Ph.D. - Publications

Affiliations: 
2012 Pharmacology & Toxicology Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Neuroscience Biology, Pharmacology
Tree Info Grants Similar researchers PubMed Report error

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Brittain MK, Brustovetsky T, Brittain JM, Khanna R, Cummins TR, Brustovetsky N. Ifenprodil, a NR2B-selective antagonist of NMDA receptor, inhibits reverse Na+/Ca2+ exchanger in neurons. Neuropharmacology. 63: 974-82. PMID 22820271 DOI: 10.1016/J.Neuropharm.2012.07.012  0.598
2012 Brittain MK, Brustovetsky T, Sheets PL, Brittain JM, Khanna R, Cummins TR, Brustovetsky N. Delayed calcium dysregulation in neurons requires both the NMDA receptor and the reverse Na+/Ca2+ exchanger. Neurobiology of Disease. 46: 109-17. PMID 22249110 DOI: 10.1016/J.Nbd.2011.12.051  0.595
2011 Brustovetsky T, Brittain MK, Sheets PL, Cummins TR, Pinelis V, Brustovetsky N. KB-R7943, an inhibitor of the reverse Na+ /Ca2+ exchanger, blocks N-methyl-D-aspartate receptor and inhibits mitochondrial complex I. British Journal of Pharmacology. 162: 255-70. PMID 20883473 DOI: 10.1111/J.1476-5381.2010.01054.X  0.572
Show low-probability matches.